These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 19797012

  • 1. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS.
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.
    Teo KY, Han B.
    J Biomech Eng; 2009 Jul 21; 131(7):074513. PubMed ID: 19640149
    [Abstract] [Full Text] [Related]

  • 6. Overcoming multidrug-resistance in cancer: statins offer a logical candidate.
    Mehta NG, Mehta M.
    Med Hypotheses; 2010 Feb 21; 74(2):237-9. PubMed ID: 19879695
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.
    Arch Pharm (Weinheim); 2008 Oct 21; 341(10):624-38. PubMed ID: 18816589
    [Abstract] [Full Text] [Related]

  • 9. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN, Shen Q, Li SS.
    Yao Xue Xue Bao; 2009 Apr 21; 44(4):333-7. PubMed ID: 19545047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
    Kibria G, Hatakeyama H, Harashima H.
    Arch Pharm Res; 2014 Jan 21; 37(1):4-15. PubMed ID: 24272889
    [Abstract] [Full Text] [Related]

  • 12. The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms.
    Isaac M, Siu A, Jongstra J.
    Drug Resist Updat; 2011 Jan 21; 14(4-5):203-11. PubMed ID: 21601509
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells.
    Li X, Chen Y, Li PC.
    Lab Chip; 2011 Apr 07; 11(7):1378-84. PubMed ID: 21327253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multifactorial nature of tumor drug resistance.
    Solyanik GI.
    Exp Oncol; 2010 Sep 07; 32(3):181-5. PubMed ID: 21403614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.